Edwards Lifesciences Corporation (EW)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Bernard J. Zovighian | CEO & Director | 2.27M | -- | 1968 |
Mr. Scott B. Ullem | Corporate VP & CFO | 1.35M | 6.36M | 1967 |
Mr. Donald E. Bobo Jr. | Corporate Vice President of Strategy & Corporate Development | 1.27M | 2.68M | 1962 |
Mr. Larry L. Wood | Corporate VP and Group President of TAVR & Surgical Structural Heart | 1.49M | 2.13M | 1966 |
Dr. Todd J. Brinton FACC, M.D. | Corporate VP of Advanced Technology & Chief Scientific Officer | -- | -- | -- |
Mark Wilterding | Vice President of Investor Relations | -- | -- | -- |
Mr. Arnold A. Pinkston | Corporate VP & General Counsel | -- | -- | 1959 |
Mr. Dirksen J. Lehman | Corporate Vice President of Public Affairs | -- | -- | -- |
Ms. Christine Z. McCauley | Corporate Vice President of Human Resources | -- | -- | 1965 |
Mr. Gary I. Sorsher | Senior Vice President of Quality & Regulatory Compliance | -- | -- | 1965 |
Edwards Lifesciences Corporation
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 19,800
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Corporate Governance
Recent Events
- Apr 25, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Mar 26, 2024DEF 14A: Proxy StatementsSee Full Filing
- Feb 12, 202410-K: Periodic Financial ReportsSee Full Filing
- Feb 06, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Jan 25, 2024SC 13G/A: Tender Offer/Acquisition ReportsSee Full Filing